Huffington Post: New Momentum on PrEP, But Critical Needs Are Overlooked
Mitchell Warren, executive director of AVAC

“…PrEP [(the use of a daily medication that reduces the risk of HIV infection)] is an option for many people, not only for gay men. … Global health leaders should be working, now, to develop and fund programs to provide access for anyone who can benefit. Oral PrEP should be integrated into comprehensive, high-impact prevention programs for all people at risk internationally, with particular attention to key populations but also for young women and married women who continue to bear the brunt of the epidemic. WHO needs to quickly issue guidance on PrEP for all of the populations that can benefit…” (7/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.